PeptidePedia The community reference

Third-party testing (revision 2)

Old revision·03:10, 3 Jul 2024·GradientGus

This is an old revision of this page, as it stood at 03:10, 3 Jul 2024, saved by GradientGus with the summary convert a hard-coded date to the house format. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Third-party testing
Also calledIndependent testing, buyer-commissioned testing
Commissioned byThe purchaser, not the supplier
Reported toThe submitter
Topic infobox · conventions

Third-party testing is the analysis of a material by a laboratory that is independent of the supplier and of the manufacturer, commissioned by the purchaser and reported to the purchaser. It is distinguished from a supplier's own certificate of analysis not by the analytical methods used, which may be identical, but by who paid for the work and who receives the result.[1]

The distinction matters because the incentive structure differs. A supplier commissioning analysis of its own material controls which sample is submitted, whether an unfavourable result is published, and how the result is described. A purchaser commissioning analysis of material already received controls none of those things but is testing a sample of unknown representativeness.[2]

References

  1. ^ United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.
  2. ^ PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see Project:Sourcing guidelines).